Insmed Incorporated Growth, Revenue, Number of Employees and Funding

Overview

Location:
Bridgewater, NJ USA
Total Funding:N/A
Industry:Biotech
Founded:N/A
Lead Investor(s):Goldman Sachs & Co. LLC, Morgan Stanley
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Insmed Incorporated's estimated revenue is currently $97.3M per year.
  • Insmed Incorporated received $437.3M in venture funding in January 2018.
  • Insmed Incorporated's estimated revenue per employee is $230998

Employee Data

  • Insmed Incorporated has 421 Employees.
  • Insmed Incorporated grew their employee count by 11% last year.
  • Insmed Incorporated currently has 22 job openings.

What Is Insmed Incorporated?

Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing company with offices in seven countries.

keywords:Biotechnology,Healthcare,Pharmaceuticals

421

Number of Employees

$97.3M

Revenue (est)

22

Current Jobs

11%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
GENEWIZ
$75.8M5283%
Hitachi Chemica...
$29.9M24213%
GENEWIZ
$75.8M5283%
Hitachi Chemica...
$29.9M24213%
Canfield Scient...
$29.3M202-32%
Thomas Scientif...
$21.5M18123%
Canfield Scient...
$29.3M202-32%
Thomas Scientif...
$21.5M18123%
L Oreal USA
N/A0N/A
L Oreal USA
N/A0N/A

Insmed Incorporated News

1 hour ago - Insmed Incorporated (INSM)- Stocks Shining Bright on Wall Street

Insmed Incorporated (NASDAQ:INSM) traded under umbrella of Healthcare sector, apart from individual factors many macro and micro factors

20-Mar-19 - Ardelyx Inc. (ARDX)'s Financial Results Comparing With Insmed

As Biotechnology businesses, Ardelyx Inc. (NASDAQ:ARDX) and Insmed Incorporated (NASDAQ:INSM), are affected by contrast.

17-Mar-19 - Alfred Altomari Sells 5500 Shares of Insmed Incorporated (NASDAQ

Insmed Incorporated (NASDAQ:INSM) Director Alfred Altomari sold 5,500 shares of the stock in a transaction that occurred on Tuesday,

Insmed Incorporated Funding

DateAmountRoundLead InvestorsReference
2003-07-14$12.0MPrivate PlacementWells Fargo SecuritiesArticle
2005-03-16$35.0MUndisclosedMultipleArticle
2007-05-07$18.2MUndisclosedCE Unterberg TowbinArticle
2012-10-01$26.0MUndisclosedArticle
2013-07-18$62.4MUndisclosedLeerink Swann LLCArticle
2014-08-13$80.0MUndisclosedArticle
2015-04-01$194.0MUndisclosedArticle
2015-04-07$223.0MUndisclosedCitigroupArticle
2017-09-08$402.5MUndisclosedGoldman Sachs & Co. LLCArticle
2018-01-24$300.0MUndisclosedGoldman Sachs & Co. LLCArticle
2018-01-25$437.3MUndisclosedGoldman Sachs & Co. LLCArticle

Insmed Incorporated Executive Hires

DateNameTitleReference
2002-01-04Frederick DunnVP Clinical DevelopmentArticle
2002-08-20Lewis StuartVP Commercial DevArticle
2002-09-10Mary CallanVP Corporate DevelopmentArticle
2003-06-20Ronald D. GunnEVPArticle
2008-07-29Jim MillerVP Process DevelopmentArticle
2009-06-16Melvin SharokyChairmanArticle
2010-03-23Nicholas A. LaBellaChief Scientific OfficerArticle
2012-05-17Donald J. HaydenChairmanArticle
2012-09-12Will LewisPresident/CEOArticle
2012-11-08Andrew DrechslerChief Financial OfficerArticle
2013-04-02Matthew PaulsChief Commercial OfficerArticle
2013-07-30Christine A. PellizzariGeneral Counsel/Corporate SecretaryArticle
2015-03-24Eugene SullivanChief Medical/Scientific OfficerArticle
2016-09-28Roger AdsettChief Commercial OfficerArticle
2019-03-28John GollChief Accounting OfficerArticle

Insmed Incorporated Acquisitions

DateCompany NameAmountNotesReference
2009-02-16Article